METACOGNITIVE THERAPY SELF-HELP FOR ANXIETY-DEPRESSION: SINGLE-BLIND RANDOMIZED FEASIBILITY TRIAL IN CARDIOVASCULAR DISEASE

Wells, A., Reeves, D., Heal, C., Fisher, P., Doherty, P., Davies, L., … & Capobianco, L. (2022). Metacognitive therapy self-help for anxiety-depression: Single-blind randomized feasibility trial in cardiovascular disease. Health Psychology, 41(5), 366.

Background: One in three cardiovascular disease (CVD) patients experience significant anxiety and depression. Current psychological interventions have limited efficacy in reducing such symptoms and are offered as a face-to-face intervention that may be a barrier to accessing treatment. We evaluated the feasibility and acceptability of delivering assisted home-based self-help metacognitive therapy (home-MCT) to cardiac rehabilitation (CR) patients experiencing anxiety and depression.